Key Takeaways
- Roche’s Genentech division announced the layoff of 141 employees, following 348 job cuts disclosed last year.
- The layoffs impacted multiple departments and were linked to broader organizational changes.
- Despite job reductions, Genentech plans to expand by hiring 400 new employees and increasing investment in a North Carolina facility.
Details on Recent Layoffs at Genentech
Roche’s Genentech division has revealed the layoff of an additional 141 staff members, adding to 348 job cuts previously reported last year. The layoffs were enacted on August 18 and were filed with California’s Employment Development Department on June 26. However, they did not appear on the department’s layoff notice list until February 4, 2026, possibly due to a system error, according to a Genentech spokesperson speaking with Fierce Biotech.
The layoffs primarily occurred at Genentech’s South San Francisco headquarters, although they were not confined to that location. The spokesperson clarified that jobs were cut across various departments and sites, similar to last year’s layoff rounds. When small layoffs in different parts of the organization exceed 50 employees collectively, a WARN notice must be issued.
The spokesperson explained that “all layoffs are associated with our headquarters in South San Francisco, regardless of what state an employee lives in.” Factors contributing to the layoffs included global manufacturing changes initiated by Roche, the integration of Genentech’s diversity and inclusion team into a wider Roche unit, and reductions across IT, research, and other sectors.
The rationale behind these tough decisions, as shared by the spokesperson, reflects the need for the company to adapt in a rapidly evolving industry: “To stay ahead, we must constantly evolve how we work,” highlighting that these changes aim to reallocate resources for better patient outcomes.
Alongside these layoffs, Genentech also experienced job reductions in other months: 143 workers were let go in July, followed by 87 in September and another 118 in November. Despite the layoffs, the spokesperson indicated that such changes could pave the way for new opportunities within the organization: “While the layoffs affect some teams, they also create new opportunities.”
In a move towards future growth, Genentech has committed to hiring over 400 new employees and has doubled its investment in a new manufacturing facility in North Carolina. This exemplifies the company’s focus on integrating digital technology, automation, and AI capabilities into its operations, signaling a commitment to innovation amid restructuring efforts.
The content above is a summary. For more details, see the source article.